{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:01:50Z","timestamp":1784584910915,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Aging-related molecular reprogramming profoundly influences melanoma progression and therapeutic sensitivity, yet underlying mechanisms remain poorly understood. We constructed a comprehensive multi-omics atlas integrating mutations, transcription, methylation, and copy number variations, utilizing the MOFA algorithm to uncover key age-driving factors. Among 20 factors, Factor6 exhibited significant negative age correlation and survival protection (HR\u2009=\u20090.95,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20094.494e-05), defined as \u201cRevitalAge Marker (RAM)\u201d. Integration of three single-cell RNA sequencing datasets revealed 4,796 RAM+ cells (predominantly endothelial cells and fibroblasts) exerting tumor-suppressive functions through VEGFA-VEGFR2 angiogenic pathways and mitochondrial ATP synthesis, while 7,229 RAM- cells (dominated by malignant cells) exhibited enhanced EMT, hypoxic adaptation, and MAPK signaling activation. RAM+ cells were governed by ZFP42 and IRF8 maintaining anti-tumor immunity, while RAM- cells controlled by ILF2 and ISL1 promoted metastasis and immune evasion, with RAM- malignant cells enriched in patients over 65 years and associated with immunotherapy resistance. Machine learning analysis of RAM-associated genes identified five core signatures (GPR143, ST3GAL4, RAB38, GMPR, FDFT1) demonstrating superior immunotherapy response prediction (AUC\u2009=\u20090.78-1.00). Drug sensitivity profiling revealed ST3GAL4 exhibited strong correlations with AZ628 (pan-RAF inhibitor) and RDEA119 (MEK inhibitor), which was further validated by molecular docking showing excellent binding affinities (binding energies: -8.7 and \u2212\u20097.2\u00a0kcal\/mol). This study provides structural evidence for targeted therapeutic strategies in ST3GAL4-overexpressing melanoma and establishes foundations for age-stratified immunotherapy.\n                  <\/jats:p>","DOI":"10.1186\/s13062-026-00860-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:06:55Z","timestamp":1781615215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell multi-omics dissection of RevitalAge Markers uncovers age-dependent immunotherapy resistance and druggable targets in melanoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Hanxiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benliang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangwei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"860_CR1","first-page":"237","volume":"23","author":"L Zhang","year":"2026","unstructured":"Zhang L, Zhang J. Cancer statistics, 2026: divergent trends and the implementation gap. Nat Reviews: Clin Oncol. 2026;23:237\u20138.","journal-title":"Nat Reviews: Clin Oncol"},{"key":"860_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.mayocp.2012.01.010","volume":"87","author":"KB Reed","year":"2012","unstructured":"Reed KB, et al. Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc. 2012;87:328\u201334.","journal-title":"Mayo Clin Proc"},{"key":"860_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.7150\/jca.2.538","volume":"2","author":"JB Macdonald","year":"2011","unstructured":"Macdonald JB, et al. Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer. 2011;2:538\u201343.","journal-title":"J Cancer"},{"key":"860_CR4","first-page":"e34742","volume":"15","author":"DC Sasson","year":"2023","unstructured":"Sasson DC, et al. Malignant Melanoma in Older Adults: Different Patient or Different Disease? Cureus. 2023;15:e34742.","journal-title":"Cureus"},{"key":"860_CR5","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622\u201334.","journal-title":"J Clin Oncol"},{"key":"860_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1245\/s10434-013-3464-x","volume":"21","author":"CM Balch","year":"2014","unstructured":"Balch CM, et al. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol. 2014;21:1075\u201381.","journal-title":"Ann Surg Oncol"},{"key":"860_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.12788\/cutis.0515","volume":"109","author":"JA Harvey","year":"2022","unstructured":"Harvey JA, et al. BRAF V600E Expression in Primary Melanoma and Its Association With Death: A Population-Based, Retrospective, Cross-Sectional Study. Cutis. 2022;109:279\u201383.","journal-title":"Cutis"},{"key":"860_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/1758834017708160","volume":"9","author":"A Boespflug","year":"2017","unstructured":"Boespflug A, Caramel J, Dalle S, Thomas L. Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date. Therapeutic Adv Med Oncol. 2017;9:481\u201392.","journal-title":"Therapeutic Adv Med Oncol"},{"key":"860_CR9","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1093\/annonc\/mdy229","volume":"29","author":"PG Corrie","year":"2018","unstructured":"Corrie PG, et al. Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Ann Oncol. 2018;29:1843\u201352.","journal-title":"Ann Oncol"},{"key":"860_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186:243\u201378.","journal-title":"Cell"},{"key":"860_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jmg.2006.043802","volume":"44","author":"AM Goldstein","year":"2007","unstructured":"Goldstein AM, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44:99\u2013106.","journal-title":"J Med Genet"},{"key":"860_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, et al. TERT promoter mutations in familial and sporadic melanoma. Science. 2013;339:959\u201361.","journal-title":"Science"},{"key":"860_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1476-4598-10-2","volume":"10","author":"D Javelaud","year":"2011","unstructured":"Javelaud D, et al. Efficient TGF-\u03b2\/SMAD signaling in human melanoma cells associated with high c-SKI\/SnoN expression. Mol Cancer. 2011;10:2.","journal-title":"Mol Cancer"},{"key":"860_CR14","doi-asserted-by":"crossref","unstructured":"Cruickshanks HA, et al. Senescent cells harbour features of the cancer epigenome. Nat Cell Biol. 2013;15:1495\u2009\u2013\u2009506.","DOI":"10.1038\/ncb2879"},{"key":"860_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","volume":"19","author":"S Horvath","year":"2018","unstructured":"Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19:371\u201384.","journal-title":"Nat Rev Genet"},{"key":"860_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-025-09435-8","volume":"646","author":"AM Jeffries","year":"2025","unstructured":"Jeffries AM, et al. Single-cell transcriptomic and genomic changes in the ageing human brain. Nature. 2025;646:657\u201366.","journal-title":"Nature"},{"key":"860_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/2159-8290.CD-18-0193","volume":"9","author":"A Kaur","year":"2019","unstructured":"Kaur A, et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 2019;9:64\u201381.","journal-title":"Cancer Discov"},{"key":"860_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-022-04774-2","volume":"606","author":"ME Fane","year":"2022","unstructured":"Fane ME, et al. Stromal changes in the aged lung induce an emergence from melanoma dormancy. Nature. 2022;606:396\u2013405.","journal-title":"Nature"},{"key":"860_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1158\/2159-8290.CD-18-0168","volume":"9","author":"BL Ecker","year":"2019","unstructured":"Ecker BL, et al. Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis. Cancer Discov. 2019;9:82\u201395.","journal-title":"Cancer Discov"},{"key":"860_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nri2959","volume":"11","author":"AN Akbar","year":"2011","unstructured":"Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol. 2011;11:289\u201395.","journal-title":"Nat Rev Immunol"},{"key":"860_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-\u017dugich","year":"2018","unstructured":"Nikolich-\u017dugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19:10\u20139.","journal-title":"Nat Immunol"},{"key":"860_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ni.2588","volume":"14","author":"JJ Goronzy","year":"2013","unstructured":"Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14:428\u201336.","journal-title":"Nat Immunol"},{"key":"860_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Reviews Cardiol. 2018;15:505\u201322.","journal-title":"Nat Reviews Cardiol"},{"key":"860_CR24","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.ccell.2023.05.004","volume":"41","author":"S Haston","year":"2023","unstructured":"Haston S, et al. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer. Cancer Cell. 2023;41:1242\u2013e12606.","journal-title":"Cancer Cell"},{"key":"860_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell. 2016;15:428\u201335.","journal-title":"Aging Cell"},{"key":"860_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li H, et al. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma. Cell. 2019;176:775\u2013e78918.","journal-title":"Cell"},{"key":"860_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189\u201396.","journal-title":"Science"},{"key":"860_CR28","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon L, et al. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Cell. 2018;175:984\u2013e99724.","journal-title":"Cell"},{"key":"860_CR29","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J, et al. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. N Engl J Med. 2019;381:1535\u201346.","journal-title":"N Engl J Med"},{"key":"860_CR30","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander N, et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat Med. 2018;24:1545\u20139.","journal-title":"Nat Med"},{"key":"860_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi NA, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348:124\u20138.","journal-title":"Science"},{"key":"860_CR32","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138.","journal-title":"Nat Med"},{"key":"860_CR33","doi-asserted-by":"crossref","unstructured":"Kugel CH, et al. 3rd age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-cell populations. Clin Cancer Res. 2018;24:5347\u20135356.","DOI":"10.1158\/1078-0432.CCR-18-1116"},{"key":"860_CR34","doi-asserted-by":"crossref","unstructured":"Moskalenko Y, et al. The impact of age on the effectiveness of immune checkpoint inhibitors therapy in patients with metastatic non-small-cell lung cancer. Geriatrics (Basel) 2025;10.","DOI":"10.20944\/preprints202502.1607.v1"},{"key":"860_CR35","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1038\/s41467-025-58512-z","volume":"16","author":"C Kao","year":"2025","unstructured":"Kao C, et al. Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors. Nat Commun. 2025;16:3531.","journal-title":"Nat Commun"},{"key":"860_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13059-020-02015-1","volume":"21","author":"R Argelaguet","year":"2020","unstructured":"Argelaguet R, et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 2020;21:111.","journal-title":"Genome Biol"},{"key":"860_CR37","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12:R41.","journal-title":"Genome Biol"},{"key":"860_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"860_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide TN, et al. Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1\/Anti-CTLA-4 Combined Therapy. Cancer Cell. 2019;35:238\u201355. e6.","journal-title":"Cancer Cell"},{"key":"860_CR40","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51:D1425\u201331.","journal-title":"Nucleic Acids Res"},{"key":"860_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163\u201372.","journal-title":"Nat Immunol"},{"key":"860_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41587-021-01091-3","volume":"40","author":"D Sun","year":"2022","unstructured":"Sun D, et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol. 2022;40:527\u201338.","journal-title":"Nat Biotechnol"},{"key":"860_CR43","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"860_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"860_CR45","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24:1277\u201389.","journal-title":"Nat Med"},{"key":"860_CR46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564:268\u201372.","journal-title":"Nature"},{"key":"860_CR47","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"860_CR48","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083\u20136.","journal-title":"Nat Methods"},{"key":"860_CR49","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-22-0563","volume":"11","author":"D Egan","year":"2023","unstructured":"Egan D, et al. Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma. Cancer Immunol Res. 2023;11:1125\u201336.","journal-title":"Cancer Immunol Res"},{"key":"860_CR50","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.1016\/j.mocell.2024.100137","volume":"47","author":"K Park","year":"2024","unstructured":"Park K, Jeon MC, Lee D, Kim JI, Im SW. Genetic and epigenetic alterations in aging and rejuvenation of human. Mol Cells. 2024;47:100137.","journal-title":"Mol Cells"},{"key":"860_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cmet.2022.11.001","volume":"35","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metab. 2023;35:12\u201335.","journal-title":"Cell Metab"},{"key":"860_CR52","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS. Ferrara, N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176:1248\u201364.","journal-title":"Cell"},{"key":"860_CR53","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1101\/gr.192526.115","volume":"26","author":"S Sun","year":"2016","unstructured":"Sun S, et al. An extended set of yeast-based functional assays accurately identifies human disease mutations. Genome Res. 2016;26:670\u201380.","journal-title":"Genome Res"},{"key":"860_CR54","first-page":"2760","volume":"9","author":"MR Guda","year":"2019","unstructured":"Guda MR, et al. Pleiotropic role of macrophage migration inhibitory factor in cancer. Am J Cancer Res. 2019;9:2760\u201373.","journal-title":"Am J Cancer Res"},{"key":"860_CR55","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-023-05961-3","volume":"14","author":"W Tang","year":"2023","unstructured":"Tang W, Chen J, Ji T, Cong X. TIGIT, a novel immune checkpoint therapy for melanoma. Cell Death Dis. 2023;14:466.","journal-title":"Cell Death Dis"},{"key":"860_CR56","doi-asserted-by":"publisher","first-page":"6940","DOI":"10.1038\/s41388-019-0906-3","volume":"38","author":"YT Zeng","year":"2019","unstructured":"Zeng YT, Liu XF, Yang WT, Zheng PS. REX1 promotes EMT-induced cell metastasis by activating the JAK2\/STAT3-signaling pathway by targeting SOCS1 in cervical cancer. Oncogene. 2019;38:6940\u201357.","journal-title":"Oncogene"},{"key":"860_CR57","doi-asserted-by":"publisher","first-page":"e25476","DOI":"10.4161\/onci.25476","volume":"2","author":"G Schiavoni","year":"2013","unstructured":"Schiavoni G, Gabriele L, Mattei F. The dual role of IRF8 in cancer immunosurveillance. Oncoimmunology. 2013;2:e25476.","journal-title":"Oncoimmunology"},{"key":"860_CR58","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","volume":"499","author":"T Jiang","year":"2021","unstructured":"Jiang T, et al. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2021;499:60\u201372.","journal-title":"Cancer Lett"},{"key":"860_CR59","first-page":"3680","volume":"41","author":"X Zhu","year":"2018","unstructured":"Zhu X, Li Y, Meng Q. Islet-1 promotes the proliferation and invasion, and inhibits the apoptosis of A375 human melanoma cells. Int J Mol Med. 2018;41:3680\u201390.","journal-title":"Int J Mol Med"},{"key":"860_CR60","doi-asserted-by":"publisher","first-page":"547","DOI":"10.20892\/j.issn.2095-3941.2020.0182","volume":"18","author":"X Zhao","year":"2021","unstructured":"Zhao X, et al. L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma. Cancer Biology Med. 2021;18:547\u201361.","journal-title":"Cancer Biology Med"},{"key":"860_CR61","doi-asserted-by":"publisher","first-page":"101893","DOI":"10.1016\/j.smim.2024.101893","volume":"74\u201375","author":"NR Mantuano","year":"2024","unstructured":"Mantuano NR, Laubli H. Sialic acid and Siglec receptors in tumor immunity and immunotherapy. Semin Immunol. 2024;74\u201375:101893.","journal-title":"Semin Immunol"},{"key":"860_CR62","doi-asserted-by":"publisher","first-page":"113599","DOI":"10.1016\/j.biopha.2022.113599","volume":"155","author":"MLP Bueno","year":"2022","unstructured":"Bueno MLP, Saad STO, Roversi FM. WNT5A in tumor development and progression: A comprehensive review. Biomed Pharmacother. 2022;155:113599.","journal-title":"Biomed Pharmacother"},{"key":"860_CR63","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41392-022-01211-8","volume":"7","author":"K Wang","year":"2022","unstructured":"Wang K, et al. Epigenetic regulation of aging: implications for interventions of aging and diseases. Signal Transduct Target Ther. 2022;7:374.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00860-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00860-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00860-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:03:25Z","timestamp":1784581405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00860-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00860-x","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"128"}}